---
title: "Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting"
description: "NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc. ( Nasdaq: MTSR ) , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic disea"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256914346.md"
published_at: "2025-09-11T11:38:34.000Z"
---

# Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

> NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc. ( Nasdaq: MTSR ) , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its portfolio of next-generation ultra-long ...

NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc. ( Nasdaq: MTSR ) , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its portfolio of next-generation ultra-long ...

### Related Stocks

- [MTSR.US - Metsera](https://longbridge.com/en/quote/MTSR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Significant opportunities exist in the global pain market for novel mechanisms and modalities | The global pain market presents significant opportunities for innovation, particularly in developing non-addictive alter | [Link](https://longbridge.com/en/news/275921122.md) |
| Maze Therapeutics Highlights Upcoming MZE829 Kidney Data, Maps Phase 2 Plans for MZE782 at Summit | Maze Therapeutics (NASDAQ: MAZE) is advancing a genetics-driven drug development approach, focusing on kidney and metabo | [Link](https://longbridge.com/en/news/275972996.md) |
| Neumora Therapeutics unveils new pipeline targeting neuropsychiatric and metabolic diseases | Neumora Therapeutics Inc. has unveiled a new pipeline focused on neuroscience drug development, targeting neuropsychiatr | [Link](https://longbridge.com/en/news/275602847.md) |
| Florida Health Dept. Proposes New Formal Rule to Slash HIV Drug Access for Thousands, Notes AHF | The Florida Department of Health has proposed a new rule that could significantly reduce access to HIV medications for o | [Link](https://longbridge.com/en/news/275629901.md) |
| BioRestorative prices $5M stock offering | BioRestorative Therapies (BRTX) priced a public offering of ~14.3M shares and warrants to purchase shares at $0.35 per s | [Link](https://longbridge.com/en/news/275707665.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.